Cargando…

Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited

BACKGROUND: Invasive infection with Streptococcus pneumoniae (pneumococci) causes significant morbidity and mortality. Case series and experimental data have shown that the capsular serotype is involved in the pathogenesis and a determinant of disease outcome. METHODS: Retrospective review of 464 ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Martens, Pernille, Worm, Signe Westring, Lundgren, Bettina, Konradsen, Helle Bossen, Benfield, Thomas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC455681/
https://www.ncbi.nlm.nih.gov/pubmed/15228629
http://dx.doi.org/10.1186/1471-2334-4-21
_version_ 1782121588337934336
author Martens, Pernille
Worm, Signe Westring
Lundgren, Bettina
Konradsen, Helle Bossen
Benfield, Thomas
author_facet Martens, Pernille
Worm, Signe Westring
Lundgren, Bettina
Konradsen, Helle Bossen
Benfield, Thomas
author_sort Martens, Pernille
collection PubMed
description BACKGROUND: Invasive infection with Streptococcus pneumoniae (pneumococci) causes significant morbidity and mortality. Case series and experimental data have shown that the capsular serotype is involved in the pathogenesis and a determinant of disease outcome. METHODS: Retrospective review of 464 cases of invasive disease among adults diagnosed between 1990 and 2001. Multivariate Cox proportional hazard analysis. RESULTS: After adjustment for other markers of disease severity, we found that infection with serotype 3 was associated with an increased relative risk (RR) of death of 2.54 (95% confidence interval (CI): 1.22–5.27), whereas infection with serotype 1 was associated with a decreased risk of death (RR 0.23 (95% CI, 0.06–0.97)). Additionally, older age, relative leucopenia and relative hypothermia were independent predictors of mortality. CONCLUSION: Our study shows that capsular serotypes independently influenced the outcome from invasive pneumococcal disease. The limitations of the current polysaccharide pneumococcal vaccine warrant the development of alternative vaccines. We suggest that the virulence of pneumococcal serotypes should be considered in the design of novel vaccines.
format Text
id pubmed-455681
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-4556812004-07-15 Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited Martens, Pernille Worm, Signe Westring Lundgren, Bettina Konradsen, Helle Bossen Benfield, Thomas BMC Infect Dis Research Article BACKGROUND: Invasive infection with Streptococcus pneumoniae (pneumococci) causes significant morbidity and mortality. Case series and experimental data have shown that the capsular serotype is involved in the pathogenesis and a determinant of disease outcome. METHODS: Retrospective review of 464 cases of invasive disease among adults diagnosed between 1990 and 2001. Multivariate Cox proportional hazard analysis. RESULTS: After adjustment for other markers of disease severity, we found that infection with serotype 3 was associated with an increased relative risk (RR) of death of 2.54 (95% confidence interval (CI): 1.22–5.27), whereas infection with serotype 1 was associated with a decreased risk of death (RR 0.23 (95% CI, 0.06–0.97)). Additionally, older age, relative leucopenia and relative hypothermia were independent predictors of mortality. CONCLUSION: Our study shows that capsular serotypes independently influenced the outcome from invasive pneumococcal disease. The limitations of the current polysaccharide pneumococcal vaccine warrant the development of alternative vaccines. We suggest that the virulence of pneumococcal serotypes should be considered in the design of novel vaccines. BioMed Central 2004-06-30 /pmc/articles/PMC455681/ /pubmed/15228629 http://dx.doi.org/10.1186/1471-2334-4-21 Text en Copyright © 2004 Martens et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Martens, Pernille
Worm, Signe Westring
Lundgren, Bettina
Konradsen, Helle Bossen
Benfield, Thomas
Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited
title Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited
title_full Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited
title_fullStr Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited
title_full_unstemmed Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited
title_short Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited
title_sort serotype-specific mortality from invasive streptococcus pneumoniae disease revisited
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC455681/
https://www.ncbi.nlm.nih.gov/pubmed/15228629
http://dx.doi.org/10.1186/1471-2334-4-21
work_keys_str_mv AT martenspernille serotypespecificmortalityfrominvasivestreptococcuspneumoniaediseaserevisited
AT wormsignewestring serotypespecificmortalityfrominvasivestreptococcuspneumoniaediseaserevisited
AT lundgrenbettina serotypespecificmortalityfrominvasivestreptococcuspneumoniaediseaserevisited
AT konradsenhellebossen serotypespecificmortalityfrominvasivestreptococcuspneumoniaediseaserevisited
AT benfieldthomas serotypespecificmortalityfrominvasivestreptococcuspneumoniaediseaserevisited